<scp>TUXEDO</scp> : a phase I/ <scp>II</scp> trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer

20224 citationsJournal Articlehybrid Open Access

Authors

Nicholas D. James · Institute of Cancer Research

Wenyu Liu · University of Birmingham

Sarah Pirrie · Cancer Research UK Clinical Trials Unit

Baljit Kaur · University of Birmingham

Carey Hendron · Cancer Research UK Clinical Trials Unit

Daniel Ford · University Hospitals Birmingham NHS Foundation Trust

Anjali Zarkar

Abstract

Phase I data demonstrate it is feasible and safe to add cetuximab to chemoradiotherapy. Exploratory analysis of phase II data provides evidence to consider further clinical evaluation of cetuximab in this setting.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Cancer Immunotherapy and Biomarkers

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Urology

Volume 131, Issue 1, pp. 63-72

DOI: 10.1111/bju.15864

Field-Weighted Citation Impact: 0.87